Press Releases from RESprotect GmbH (1 total)
RESprotect Elucidates The Mode Of Action Of Its Anti-Cancer Drug RP101: Binding …
Dresden/Germany - March 31, 2009 - RESprotect GmbH announced that its anti-cancer drug RP101 is the first small molecule known to bind to heat shock…
Go To Page:
